

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | negative regulation of cell killing (GO:0031342) | 4.57441350 |
| 2 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.57441350 |
| 3 | response to peptidoglycan (GO:0032494) | 4.47617948 |
| 4 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 4.41217646 |
| 5 | vocalization behavior (GO:0071625) | 4.36743457 |
| 6 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 4.30852685 |
| 7 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 4.30550521 |
| 8 | macrophage activation involved in immune response (GO:0002281) | 4.27497838 |
| 9 | modulation by symbiont of host defense response (GO:0052031) | 4.18987937 |
| 10 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.18987937 |
| 11 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.18987937 |
| 12 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.18987937 |
| 13 | modulation by symbiont of host immune response (GO:0052553) | 4.18987937 |
| 14 | positive regulation by symbiont of host defense response (GO:0052509) | 4.18987937 |
| 15 | neuron cell-cell adhesion (GO:0007158) | 4.18207051 |
| 16 | regulation of glutamate receptor signaling pathway (GO:1900449) | 3.98419541 |
| 17 | leukocyte aggregation (GO:0070486) | 3.97219168 |
| 18 | regulation of synapse structural plasticity (GO:0051823) | 3.95561408 |
| 19 | negative regulation of interleukin-12 production (GO:0032695) | 3.94971548 |
| 20 | protein localization to synapse (GO:0035418) | 3.93847676 |
| 21 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.92276772 |
| 22 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.91296125 |
| 23 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.90949225 |
| 24 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 3.90131115 |
| 25 | synaptic vesicle exocytosis (GO:0016079) | 3.86299510 |
| 26 | glutamate secretion (GO:0014047) | 3.84344393 |
| 27 | synaptic vesicle maturation (GO:0016188) | 3.82620108 |
| 28 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.79940367 |
| 29 | detection of other organism (GO:0098543) | 3.77215260 |
| 30 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.76911807 |
| 31 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.76545824 |
| 32 | mannose metabolic process (GO:0006013) | 3.70061614 |
| 33 | regulation of synaptic vesicle exocytosis (GO:2000300) | 3.70025226 |
| 34 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.69474582 |
| 35 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.68545382 |
| 36 | neutrophil activation involved in immune response (GO:0002283) | 3.68223390 |
| 37 | detection of bacterium (GO:0016045) | 3.66176049 |
| 38 | germinal center formation (GO:0002467) | 3.65169439 |
| 39 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.61655497 |
| 40 | locomotory exploration behavior (GO:0035641) | 3.58060279 |
| 41 | regulation of synaptic vesicle transport (GO:1902803) | 3.56820159 |
| 42 | detection of molecule of bacterial origin (GO:0032490) | 3.55424079 |
| 43 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.54126388 |
| 44 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.52433664 |
| 45 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.50083221 |
| 46 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.50052004 |
| 47 | response to muramyl dipeptide (GO:0032495) | 3.48504106 |
| 48 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.47063502 |
| 49 | detection of external biotic stimulus (GO:0098581) | 3.42363651 |
| 50 | response to type I interferon (GO:0034340) | 3.41678945 |
| 51 | cellular response to type I interferon (GO:0071357) | 3.38302919 |
| 52 | type I interferon signaling pathway (GO:0060337) | 3.38302919 |
| 53 | neuronal action potential propagation (GO:0019227) | 3.34740967 |
| 54 | synaptic transmission, glutamatergic (GO:0035249) | 3.32645375 |
| 55 | glutamate receptor signaling pathway (GO:0007215) | 3.31845026 |
| 56 | postsynaptic membrane organization (GO:0001941) | 3.28422946 |
| 57 | immunoglobulin mediated immune response (GO:0016064) | 3.27203866 |
| 58 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.26748945 |
| 59 | dendritic spine morphogenesis (GO:0060997) | 3.26420715 |
| 60 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.24064713 |
| 61 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 3.22361277 |
| 62 | regulation of mast cell degranulation (GO:0043304) | 3.22020833 |
| 63 | synaptic vesicle endocytosis (GO:0048488) | 3.21135391 |
| 64 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.19665043 |
| 65 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.18966729 |
| 66 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 3.16506054 |
| 67 | leukocyte migration involved in inflammatory response (GO:0002523) | 3.15897577 |
| 68 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.14542004 |
| 69 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.13585582 |
| 70 | neurotransmitter secretion (GO:0007269) | 3.10610115 |
| 71 | neuron recognition (GO:0008038) | 3.07699484 |
| 72 | detection of biotic stimulus (GO:0009595) | 3.07196154 |
| 73 | negative regulation of cytokine production involved in immune response (GO:0002719) | 3.06326433 |
| 74 | regulation of leukocyte degranulation (GO:0043300) | 3.06105805 |
| 75 | regulation of postsynaptic membrane potential (GO:0060078) | 3.05308653 |
| 76 | NIK/NF-kappaB signaling (GO:0038061) | 3.03913840 |
| 77 | neuron-neuron synaptic transmission (GO:0007270) | 3.01376830 |
| 78 | membrane depolarization during action potential (GO:0086010) | 3.00440194 |
| 79 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.99625688 |
| 80 | cerebellar Purkinje cell differentiation (GO:0021702) | 2.98279270 |
| 81 | defense response to protozoan (GO:0042832) | 2.98161718 |
| 82 | exploration behavior (GO:0035640) | 2.97790988 |
| 83 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 2.97597411 |
| 84 | presynaptic membrane assembly (GO:0097105) | 2.97487140 |
| 85 | positive regulation of membrane potential (GO:0045838) | 2.96026140 |
| 86 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 2.94782860 |
| 87 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.93954677 |
| 88 | macrophage activation (GO:0042116) | 2.93258915 |
| 89 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.91753196 |
| 90 | neuronal ion channel clustering (GO:0045161) | 2.91449324 |
| 91 | pyrimidine nucleobase catabolic process (GO:0006208) | 2.91166025 |
| 92 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.90862518 |
| 93 | positive regulation of type 2 immune response (GO:0002830) | 2.90827595 |
| 94 | membrane depolarization (GO:0051899) | 2.90357237 |
| 95 | regulation of gamma-delta T cell activation (GO:0046643) | 2.89016113 |
| 96 | regulation of regulated secretory pathway (GO:1903305) | 2.88293747 |
| 97 | myeloid cell activation involved in immune response (GO:0002275) | 2.86806953 |
| 98 | granulocyte activation (GO:0036230) | 2.85783460 |
| 99 | layer formation in cerebral cortex (GO:0021819) | 2.85598270 |
| 100 | negative regulation of innate immune response (GO:0045824) | 2.84421271 |
| 101 | response to pheromone (GO:0019236) | 2.84250409 |
| 102 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.82236103 |
| 103 | adenosine receptor signaling pathway (GO:0001973) | 2.82113874 |
| 104 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 2.81044127 |
| 105 | neutrophil activation (GO:0042119) | 2.80488742 |
| 106 | long-term memory (GO:0007616) | 2.80137864 |
| 107 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.79586518 |
| 108 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 2.78729642 |
| 109 | dendrite morphogenesis (GO:0048813) | 2.77301312 |
| 110 | regulation of type 2 immune response (GO:0002828) | 2.76677778 |
| 111 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.76428370 |
| 112 | regulation of vesicle fusion (GO:0031338) | 2.74622105 |
| 113 | response to protozoan (GO:0001562) | 2.73656201 |
| 114 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.73491003 |
| 115 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.72534033 |
| 116 | negative regulation of T cell mediated immunity (GO:0002710) | 2.71027024 |
| 117 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.70455910 |
| 118 | response to host immune response (GO:0052572) | 2.70455910 |
| 119 | presynaptic membrane organization (GO:0097090) | 2.70190057 |
| 120 | negative regulation of type 2 immune response (GO:0002829) | 2.69042759 |
| 121 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 2.67518982 |
| 122 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 2.67072723 |
| 123 | negative regulation of interleukin-6 production (GO:0032715) | 2.66386441 |
| 124 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 2.64969786 |
| 125 | response to auditory stimulus (GO:0010996) | 2.64688499 |
| 126 | prepulse inhibition (GO:0060134) | 2.64089027 |
| 127 | regulation of toll-like receptor signaling pathway (GO:0034121) | 2.63698939 |
| 128 | axonal fasciculation (GO:0007413) | 2.63613436 |
| 129 | negative regulation of tumor necrosis factor production (GO:0032720) | 2.63477158 |
| 130 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 2.63398407 |
| 131 | gamma-aminobutyric acid transport (GO:0015812) | 2.61440436 |
| 132 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.60289827 |
| 133 | central nervous system projection neuron axonogenesis (GO:0021952) | 2.59320826 |
| 134 | auditory behavior (GO:0031223) | 2.58979532 |
| 135 | synapse assembly (GO:0007416) | 2.57705511 |
| 136 | cellular extravasation (GO:0045123) | 2.57367207 |
| 137 | negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556) | 2.55683980 |
| 138 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 2.55593249 |
| 139 | positive thymic T cell selection (GO:0045059) | 2.55508311 |
| 140 | response to host (GO:0075136) | 2.55372247 |
| 141 | response to host defenses (GO:0052200) | 2.55372247 |
| 142 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.55372247 |
| 143 | regulation of synaptic transmission, GABAergic (GO:0032228) | 2.54960041 |
| 144 | calcium ion import (GO:0070509) | 2.52555489 |
| 145 | regulation of synaptic plasticity (GO:0048167) | 2.52269331 |
| 146 | tolerance induction (GO:0002507) | 2.51567394 |
| 147 | respiratory burst (GO:0045730) | 2.51117377 |
| 148 | regulation of T cell tolerance induction (GO:0002664) | 2.50955526 |
| 149 | signal complex assembly (GO:0007172) | 2.50701569 |
| 150 | regulation of interferon-alpha production (GO:0032647) | 2.50084992 |
| 151 | neurotransmitter transport (GO:0006836) | 2.49541297 |
| 152 | nucleobase catabolic process (GO:0046113) | 2.49512211 |
| 153 | positive regulation of neurotransmitter secretion (GO:0001956) | 2.49162812 |
| 154 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.48884357 |
| 155 | myeloid dendritic cell differentiation (GO:0043011) | 2.48820824 |
| 156 | regulation of neurotransmitter secretion (GO:0046928) | 2.48550714 |
| 157 | transmission of nerve impulse (GO:0019226) | 2.47708246 |
| 158 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.47278891 |
| 159 | positive regulation of antigen processing and presentation (GO:0002579) | 2.47273726 |
| 160 | glycine transport (GO:0015816) | 2.46838923 |
| 161 | regulation of antigen processing and presentation (GO:0002577) | 2.45914238 |
| 162 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.45732677 |
| 163 | learning (GO:0007612) | 2.45674951 |
| 164 | T-helper 1 type immune response (GO:0042088) | 2.44478318 |
| 165 | positive regulation of protein dephosphorylation (GO:0035307) | 2.44042537 |
| 166 | regulation of ARF protein signal transduction (GO:0032012) | 2.43272436 |
| 167 | striatum development (GO:0021756) | 2.42370920 |
| 168 | positive regulation of interferon-alpha production (GO:0032727) | 2.41868630 |
| 169 | mechanosensory behavior (GO:0007638) | 2.41364940 |
| 170 | regulation of tumor necrosis factor superfamily cytokine production (GO:1903555) | 2.40562629 |
| 171 | long-term synaptic potentiation (GO:0060291) | 2.40464319 |
| 172 | response to manganese ion (GO:0010042) | 2.40218694 |
| 173 | negative regulation of production of molecular mediator of immune response (GO:0002701) | 2.40063335 |
| 174 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.38601426 |
| 175 | microglial cell activation (GO:0001774) | 2.37455208 |
| 176 | regulation of mast cell activation (GO:0033003) | 2.37344822 |
| 177 | cell communication by electrical coupling (GO:0010644) | 2.37044361 |
| 178 | positive regulation of synapse assembly (GO:0051965) | 2.35999355 |
| 179 | visual learning (GO:0008542) | 2.33564302 |
| 180 | positive regulation of neurotransmitter transport (GO:0051590) | 2.31626249 |
| 181 | regulation of neurotransmitter transport (GO:0051588) | 2.31181953 |
| 182 | positive regulation of dendritic spine development (GO:0060999) | 2.30887057 |
| 183 | regulation of neurotransmitter levels (GO:0001505) | 2.30440605 |
| 184 | regulation of ARF GTPase activity (GO:0032312) | 2.30326154 |
| 185 | adult walking behavior (GO:0007628) | 2.29867068 |
| 186 | phosphorelay signal transduction system (GO:0000160) | 2.29397872 |
| 187 | detection of calcium ion (GO:0005513) | 2.28433066 |
| 188 | activation of protein kinase A activity (GO:0034199) | 2.28182007 |
| 189 | membrane hyperpolarization (GO:0060081) | 2.27779661 |
| 190 | neurological system process involved in regulation of systemic arterial blood pressure (GO:0001976) | 2.27376222 |
| 191 | positive regulation of synaptic transmission (GO:0050806) | 2.27373042 |
| 192 | regulation of synapse maturation (GO:0090128) | 2.27043740 |
| 193 | dopamine receptor signaling pathway (GO:0007212) | 2.26999468 |
| 194 | proline transport (GO:0015824) | 2.26950119 |
| 195 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 2.25935316 |
| 196 | cAMP-mediated signaling (GO:0019933) | 2.25458130 |
| 197 | dendritic spine organization (GO:0097061) | 2.24436941 |
| 198 | establishment of synaptic vesicle localization (GO:0097480) | 2.24365542 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.57971055 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.55899764 |
| 3 | VDR_21846776_ChIP-Seq_THP-1_Human | 3.14515538 |
| 4 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.91315610 |
| 5 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.89570132 |
| 6 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.75709169 |
| 7 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.69349641 |
| 8 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.58694470 |
| 9 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.55992014 |
| 10 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.47366773 |
| 11 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.32890495 |
| 12 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.29743901 |
| 13 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.29570271 |
| 14 | KDM2B_26808549_Chip-Seq_DND41_Human | 2.27624004 |
| 15 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.25238575 |
| 16 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.23181733 |
| 17 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.21947635 |
| 18 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.21886915 |
| 19 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.21886915 |
| 20 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.21695479 |
| 21 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.18806235 |
| 22 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.17926495 |
| 23 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.17660575 |
| 24 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 2.16835541 |
| 25 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.16802358 |
| 26 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.15503189 |
| 27 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.13970169 |
| 28 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.12698697 |
| 29 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.10676600 |
| 30 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.09318033 |
| 31 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.00967238 |
| 32 | MYC_22102868_ChIP-Seq_BL_Human | 1.99320121 |
| 33 | P68_20966046_ChIP-Seq_HELA_Human | 1.99295416 |
| 34 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.97688492 |
| 35 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.97317270 |
| 36 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.96887466 |
| 37 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.96325232 |
| 38 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.96093975 |
| 39 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.95149850 |
| 40 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.93738118 |
| 41 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.92093855 |
| 42 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.91574417 |
| 43 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.90789056 |
| 44 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.89464861 |
| 45 | MAF_26560356_Chip-Seq_TH1_Human | 1.87814545 |
| 46 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.87115106 |
| 47 | MAF_26560356_Chip-Seq_TH2_Human | 1.84325587 |
| 48 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.83800388 |
| 49 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.81219754 |
| 50 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.80981555 |
| 51 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.73361364 |
| 52 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.72499272 |
| 53 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.69885027 |
| 54 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.69835711 |
| 55 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.68867773 |
| 56 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.68535402 |
| 57 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.67547665 |
| 58 | UTX_26944678_Chip-Seq_JUKART_Human | 1.67110371 |
| 59 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.65039414 |
| 60 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.65017184 |
| 61 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.64148138 |
| 62 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.62517887 |
| 63 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.58009079 |
| 64 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.57208629 |
| 65 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.55564887 |
| 66 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.55060092 |
| 67 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.53737681 |
| 68 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.53376067 |
| 69 | SPI1_23127762_ChIP-Seq_K562_Human | 1.52755820 |
| 70 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.52472395 |
| 71 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.52057498 |
| 72 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.50834729 |
| 73 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.49146944 |
| 74 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.48482551 |
| 75 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.48275015 |
| 76 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.47346864 |
| 77 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.46871571 |
| 78 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.46705735 |
| 79 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.45422647 |
| 80 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.44320512 |
| 81 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.41625653 |
| 82 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.41479308 |
| 83 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.40046647 |
| 84 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.39548458 |
| 85 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.38511489 |
| 86 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.34081714 |
| 87 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.33105566 |
| 88 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.32213748 |
| 89 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.31249036 |
| 90 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.31117866 |
| 91 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.30449695 |
| 92 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.28014350 |
| 93 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.27797849 |
| 94 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.27713735 |
| 95 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.27644970 |
| 96 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.26750409 |
| 97 | SA1_27219007_Chip-Seq_Bcells_Human | 1.26233066 |
| 98 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.26104898 |
| 99 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.26066752 |
| 100 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.25704773 |
| 101 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.25120476 |
| 102 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.24480948 |
| 103 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.24392995 |
| 104 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.24205728 |
| 105 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.21403270 |
| 106 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.21351812 |
| 107 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.19661769 |
| 108 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.17096236 |
| 109 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.16962938 |
| 110 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.16351572 |
| 111 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.16305745 |
| 112 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.15445900 |
| 113 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 1.15287256 |
| 114 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.14480851 |
| 115 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.14324675 |
| 116 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 1.14246400 |
| 117 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.13606529 |
| 118 | CTCF_20526341_ChIP-Seq_ESCs_Human | 1.13314768 |
| 119 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.13109306 |
| 120 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.13048920 |
| 121 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.13007757 |
| 122 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.12443155 |
| 123 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.12395098 |
| 124 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.12229839 |
| 125 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.11210531 |
| 126 | P300_19829295_ChIP-Seq_ESCs_Human | 1.11174831 |
| 127 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.10926088 |
| 128 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.09874608 |
| 129 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.09123447 |
| 130 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.09032545 |
| 131 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.08205277 |
| 132 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.07102336 |
| 133 | TP63_22573176_ChIP-Seq_HFKS_Human | 1.06478539 |
| 134 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.05992848 |
| 135 | AR_25329375_ChIP-Seq_VCAP_Human | 1.04797630 |
| 136 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.04661047 |
| 137 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.04623761 |
| 138 | OCT4_19829295_ChIP-Seq_ESCs_Human | 1.03442298 |
| 139 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.02908422 |
| 140 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.02609981 |
| 141 | CTCF_21964334_Chip-Seq_Bcells_Human | 1.02402296 |
| 142 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.02086929 |
| 143 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.01668879 |
| 144 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.01488764 |
| 145 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.01093580 |
| 146 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.00216320 |
| 147 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.00138059 |
| 148 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.98539683 |
| 149 | TCF4_23295773_ChIP-Seq_U87_Human | 0.97319476 |
| 150 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.96578770 |
| 151 | STAT3_23295773_ChIP-Seq_U87_Human | 0.95846155 |
| 152 | AR_19668381_ChIP-Seq_PC3_Human | 0.93810341 |
| 153 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.93359773 |
| 154 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 0.92651219 |
| 155 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.92273700 |
| 156 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.90541461 |
| 157 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.90541461 |
| 158 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.89740456 |
| 159 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.89706156 |
| 160 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.89071821 |
| 161 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.88994750 |
| 162 | RNF2_27304074_Chip-Seq_NSC_Mouse | 0.88742054 |
| 163 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.87770484 |
| 164 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.86778245 |
| 165 | KDM2B_26808549_Chip-Seq_K562_Human | 0.85932385 |
| 166 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.85428402 |
| 167 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.85365446 |
| 168 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 0.85237647 |
| 169 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.84300319 |
| 170 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.83738628 |
| 171 | KDM2B_26808549_Chip-Seq_REH_Human | 0.83642914 |
| 172 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.83058894 |
| 173 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.83052978 |
| 174 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.82482577 |
| 175 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.82458602 |
| 176 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.81761502 |
| 177 | P53_22387025_ChIP-Seq_ESCs_Mouse | 0.80905851 |
| 178 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.80855793 |
| 179 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.80249351 |
| 180 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 0.79853022 |
| 181 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.79705380 |
| 182 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.79379697 |
| 183 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.79282203 |
| 184 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.78579887 |
| 185 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.78545942 |
| 186 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.78375330 |
| 187 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.78355734 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 5.34684575 |
| 2 | MP0003303_peritoneal_inflammation | 4.26973138 |
| 3 | MP0003436_decreased_susceptibility_to | 4.15046263 |
| 4 | MP0003880_abnormal_central_pattern | 4.05830354 |
| 5 | MP0003724_increased_susceptibility_to | 4.05755564 |
| 6 | MP0003635_abnormal_synaptic_transmissio | 3.45629293 |
| 7 | MP0005058_abnormal_lysosome_morphology | 3.20942062 |
| 8 | MP0009745_abnormal_behavioral_response | 2.96735924 |
| 9 | MP0002063_abnormal_learning/memory/cond | 2.82411033 |
| 10 | MP0002064_seizures | 2.65817229 |
| 11 | MP0005423_abnormal_somatic_nervous | 2.61818303 |
| 12 | MP0002419_abnormal_innate_immunity | 2.59418800 |
| 13 | MP0001984_abnormal_olfaction | 2.57381974 |
| 14 | MP0006082_CNS_inflammation | 2.52386125 |
| 15 | MP0002572_abnormal_emotion/affect_behav | 2.50321260 |
| 16 | MP0004270_analgesia | 2.49900980 |
| 17 | MP0005025_abnormal_response_to | 2.48280738 |
| 18 | MP0001968_abnormal_touch/_nociception | 2.46652595 |
| 19 | MP0001835_abnormal_antigen_presentation | 2.42861442 |
| 20 | MP0009785_altered_susceptibility_to | 2.41304765 |
| 21 | MP0009278_abnormal_bone_marrow | 2.33903864 |
| 22 | MP0009046_muscle_twitch | 2.33473451 |
| 23 | MP0005387_immune_system_phenotype | 2.27079300 |
| 24 | MP0001790_abnormal_immune_system | 2.27079300 |
| 25 | MP0005645_abnormal_hypothalamus_physiol | 2.26890934 |
| 26 | MP0005000_abnormal_immune_tolerance | 2.26249524 |
| 27 | MP0001533_abnormal_skeleton_physiology | 2.21865122 |
| 28 | MP0001486_abnormal_startle_reflex | 2.18617985 |
| 29 | MP0002148_abnormal_hypersensitivity_rea | 2.14846349 |
| 30 | MP0005646_abnormal_pituitary_gland | 2.14453596 |
| 31 | MP0002272_abnormal_nervous_system | 2.12253485 |
| 32 | MP0009840_abnormal_foam_cell | 2.11344039 |
| 33 | MP0001440_abnormal_grooming_behavior | 2.08088519 |
| 34 | MP0000569_abnormal_digit_pigmentation | 2.07246210 |
| 35 | MP0002822_catalepsy | 2.02608109 |
| 36 | MP0002736_abnormal_nociception_after | 2.02022070 |
| 37 | MP0002723_abnormal_immune_serum | 1.99855301 |
| 38 | MP0001800_abnormal_humoral_immune | 1.98533667 |
| 39 | MP0008260_abnormal_autophagy | 1.96399728 |
| 40 | MP0002735_abnormal_chemical_nociception | 1.94607740 |
| 41 | MP0000685_abnormal_immune_system | 1.91493054 |
| 42 | MP0002837_dystrophic_cardiac_calcinosis | 1.90590918 |
| 43 | MP0005671_abnormal_response_to | 1.90507654 |
| 44 | MP0003300_gastrointestinal_ulcer | 1.89922201 |
| 45 | MP0006276_abnormal_autonomic_nervous | 1.89310747 |
| 46 | MP0002734_abnormal_mechanical_nocicepti | 1.88055991 |
| 47 | MP0002452_abnormal_antigen_presenting | 1.85809608 |
| 48 | MP0004947_skin_inflammation | 1.84812374 |
| 49 | MP0003191_abnormal_cellular_cholesterol | 1.82294805 |
| 50 | MP0002557_abnormal_social/conspecific_i | 1.82117160 |
| 51 | MP0002420_abnormal_adaptive_immunity | 1.80887158 |
| 52 | MP0001819_abnormal_immune_cell | 1.80726056 |
| 53 | MP0003787_abnormal_imprinting | 1.78993416 |
| 54 | MP0002733_abnormal_thermal_nociception | 1.78609029 |
| 55 | MP0001501_abnormal_sleep_pattern | 1.78556828 |
| 56 | MP0004510_myositis | 1.77267135 |
| 57 | MP0002067_abnormal_sensory_capabilities | 1.75185697 |
| 58 | MP0001502_abnormal_circadian_rhythm | 1.74492167 |
| 59 | MP0001970_abnormal_pain_threshold | 1.73077536 |
| 60 | MP0003705_abnormal_hypodermis_morpholog | 1.70569487 |
| 61 | MP0000778_abnormal_nervous_system | 1.68582831 |
| 62 | MP0003879_abnormal_hair_cell | 1.57745757 |
| 63 | MP0004811_abnormal_neuron_physiology | 1.54392225 |
| 64 | MP0010155_abnormal_intestine_physiology | 1.51959052 |
| 65 | MP0002184_abnormal_innervation | 1.50016049 |
| 66 | MP0009764_decreased_sensitivity_to | 1.47885009 |
| 67 | MP0002405_respiratory_system_inflammati | 1.46514337 |
| 68 | MP0001845_abnormal_inflammatory_respons | 1.45328247 |
| 69 | MP0000751_myopathy | 1.44768175 |
| 70 | MP0001188_hyperpigmentation | 1.42304058 |
| 71 | MP0003329_amyloid_beta_deposits | 1.42087761 |
| 72 | MP0005464_abnormal_platelet_physiology | 1.41838561 |
| 73 | MP0006292_abnormal_olfactory_placode | 1.37356051 |
| 74 | MP0004858_abnormal_nervous_system | 1.36882131 |
| 75 | MP0008469_abnormal_protein_level | 1.35637858 |
| 76 | MP0009333_abnormal_splenocyte_physiolog | 1.35098609 |
| 77 | MP0008569_lethality_at_weaning | 1.33466110 |
| 78 | MP0004381_abnormal_hair_follicle | 1.33213735 |
| 79 | MP0005409_darkened_coat_color | 1.31993092 |
| 80 | MP0003646_muscle_fatigue | 1.31249151 |
| 81 | MP0000716_abnormal_immune_system | 1.29302447 |
| 82 | MP0002998_abnormal_bone_remodeling | 1.29221285 |
| 83 | MP0001529_abnormal_vocalization | 1.26147379 |
| 84 | MP0003453_abnormal_keratinocyte_physiol | 1.25759828 |
| 85 | MP0001986_abnormal_taste_sensitivity | 1.25052935 |
| 86 | MP0008004_abnormal_stomach_pH | 1.23883088 |
| 87 | MP0002933_joint_inflammation | 1.23877611 |
| 88 | MP0000858_altered_metastatic_potential | 1.23496552 |
| 89 | MP0004145_abnormal_muscle_electrophysio | 1.23160149 |
| 90 | MP0001958_emphysema | 1.22820251 |
| 91 | MP0000015_abnormal_ear_pigmentation | 1.22571156 |
| 92 | MP0003633_abnormal_nervous_system | 1.21650769 |
| 93 | MP0005166_decreased_susceptibility_to | 1.20771139 |
| 94 | MP0001849_ear_inflammation | 1.19935058 |
| 95 | MP0005397_hematopoietic_system_phenotyp | 1.19412381 |
| 96 | MP0001545_abnormal_hematopoietic_system | 1.19412381 |
| 97 | MP0004742_abnormal_vestibular_system | 1.19022067 |
| 98 | MP0002398_abnormal_bone_marrow | 1.17442360 |
| 99 | MP0002882_abnormal_neuron_morphology | 1.16788559 |
| 100 | MP0002066_abnormal_motor_capabilities/c | 1.16534663 |
| 101 | MP0000955_abnormal_spinal_cord | 1.15908296 |
| 102 | MP0004924_abnormal_behavior | 1.14147917 |
| 103 | MP0005386_behavior/neurological_phenoty | 1.14147917 |
| 104 | MP0005451_abnormal_body_composition | 1.12650055 |
| 105 | MP0003122_maternal_imprinting | 1.12189677 |
| 106 | MP0009780_abnormal_chondrocyte_physiolo | 1.11201329 |
| 107 | MP0002638_abnormal_pupillary_reflex | 1.10578182 |
| 108 | MP0003279_aneurysm | 1.09155004 |
| 109 | MP0005535_abnormal_body_temperature | 1.08395328 |
| 110 | MP0000343_altered_response_to | 1.08258163 |
| 111 | MP0002132_abnormal_respiratory_system | 1.06858277 |
| 112 | MP0003075_altered_response_to | 1.06299172 |
| 113 | MP0010386_abnormal_urinary_bladder | 1.06036068 |
| 114 | MP0003828_pulmonary_edema | 1.05737472 |
| 115 | MP0003763_abnormal_thymus_physiology | 1.05525994 |
| 116 | MP0005167_abnormal_blood-brain_barrier | 1.05525600 |
| 117 | MP0005390_skeleton_phenotype | 1.05243775 |
| 118 | MP0005551_abnormal_eye_electrophysiolog | 1.04040879 |
| 119 | MP0000465_gastrointestinal_hemorrhage | 1.02213914 |
| 120 | MP0003448_altered_tumor_morphology | 1.01774196 |
| 121 | MP0002429_abnormal_blood_cell | 1.01180158 |
| 122 | MP0005310_abnormal_salivary_gland | 1.00258383 |
| 123 | MP0002069_abnormal_eating/drinking_beha | 0.98805978 |
| 124 | MP0003806_abnormal_nucleotide_metabolis | 0.97892581 |
| 125 | MP0003283_abnormal_digestive_organ | 0.97343619 |
| 126 | MP0001873_stomach_inflammation | 0.96911510 |
| 127 | MP0003172_abnormal_lysosome_physiology | 0.96597334 |
| 128 | MP0004142_abnormal_muscle_tone | 0.96257460 |
| 129 | MP0003631_nervous_system_phenotype | 0.94977396 |
| 130 | MP0008961_abnormal_basal_metabolism | 0.93792210 |
| 131 | MP0004885_abnormal_endolymph | 0.92875215 |
| 132 | MP0002909_abnormal_adrenal_gland | 0.90502860 |
| 133 | MP0002722_abnormal_immune_system | 0.90093132 |
| 134 | MP0002229_neurodegeneration | 0.90006913 |
| 135 | MP0003866_abnormal_defecation | 0.89821261 |
| 136 | MP0002928_abnormal_bile_duct | 0.89620693 |
| 137 | MP0005174_abnormal_tail_pigmentation | 0.89425997 |
| 138 | MP0003183_abnormal_peptide_metabolism | 0.88548952 |
| 139 | MP0001905_abnormal_dopamine_level | 0.88355804 |
| 140 | MP0005076_abnormal_cell_differentiation | 0.86739636 |
| 141 | MP0008874_decreased_physiological_sensi | 0.86435328 |
| 142 | MP0002332_abnormal_exercise_endurance | 0.86004350 |
| 143 | MP0004130_abnormal_muscle_cell | 0.85887107 |
| 144 | MP0000689_abnormal_spleen_morphology | 0.85048066 |
| 145 | MP0001663_abnormal_digestive_system | 0.82898217 |
| 146 | MP0005083_abnormal_biliary_tract | 0.81980142 |
| 147 | MP0004085_abnormal_heartbeat | 0.81784830 |
| 148 | MP0003252_abnormal_bile_duct | 0.81744904 |
| 149 | MP0000604_amyloidosis | 0.81290460 |
| 150 | MP0000678_abnormal_parathyroid_gland | 0.81210609 |
| 151 | MP0005164_abnormal_response_to | 0.80498141 |
| 152 | MP0001963_abnormal_hearing_physiology | 0.79711856 |
| 153 | MP0003137_abnormal_impulse_conducting | 0.78928875 |
| 154 | MP0005499_abnormal_olfactory_system | 0.78796229 |
| 155 | MP0005394_taste/olfaction_phenotype | 0.78796229 |
| 156 | MP0005365_abnormal_bile_salt | 0.78593467 |
| 157 | MP0002277_abnormal_respiratory_mucosa | 0.78517516 |
| 158 | MP0002090_abnormal_vision | 0.78256392 |
| 159 | MP0004043_abnormal_pH_regulation | 0.76312184 |
| 160 | MP0008872_abnormal_physiological_respon | 0.75772900 |
| 161 | MP0004883_abnormal_blood_vessel | 0.75610169 |
| 162 | MP0000703_abnormal_thymus_morphology | 0.75356452 |
| 163 | MP0002653_abnormal_ependyma_morphology | 0.73305499 |
| 164 | MP0002152_abnormal_brain_morphology | 0.72499602 |
| 165 | MP0003690_abnormal_glial_cell | 0.71946498 |
| 166 | MP0002102_abnormal_ear_morphology | 0.71908902 |
| 167 | MP0000631_abnormal_neuroendocrine_gland | 0.71194593 |
| 168 | MP0000749_muscle_degeneration | 0.67062968 |
| 169 | MP0000920_abnormal_myelination | 0.66615612 |
| 170 | MP0001853_heart_inflammation | 0.66308462 |
| 171 | MP0004215_abnormal_myocardial_fiber | 0.65721931 |
| 172 | MP0002254_reproductive_system_inflammat | 0.65155121 |
| 173 | MP0002752_abnormal_somatic_nervous | 0.64686255 |
| 174 | MP0003091_abnormal_cell_migration | 0.64121074 |
| 175 | MP0000750_abnormal_muscle_regeneration | 0.64089374 |
| 176 | MP0002138_abnormal_hepatobiliary_system | 0.63575746 |
| 177 | MP0003795_abnormal_bone_structure | 0.63240706 |
| 178 | MP0005377_hearing/vestibular/ear_phenot | 0.61707471 |
| 179 | MP0000026_abnormal_inner_ear | 0.60618766 |
| 180 | MP0005448_abnormal_energy_balance | 0.59423155 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 6.48660713 |
| 2 | Febrile seizures (HP:0002373) | 4.76253180 |
| 3 | Eczematoid dermatitis (HP:0000976) | 4.67339716 |
| 4 | Myositis (HP:0100614) | 4.53712274 |
| 5 | Myokymia (HP:0002411) | 4.51652304 |
| 6 | Focal seizures (HP:0007359) | 4.45935622 |
| 7 | Abnormality of macrophages (HP:0004311) | 4.30054989 |
| 8 | Orchitis (HP:0100796) | 4.28585142 |
| 9 | Visual hallucinations (HP:0002367) | 4.21731656 |
| 10 | Epileptic encephalopathy (HP:0200134) | 4.14000096 |
| 11 | Recurrent abscess formation (HP:0002722) | 4.07532556 |
| 12 | Recurrent bacterial skin infections (HP:0005406) | 4.07087640 |
| 13 | Optic neuritis (HP:0100653) | 3.91742860 |
| 14 | Retrobulbar optic neuritis (HP:0100654) | 3.91742860 |
| 15 | Stomatitis (HP:0010280) | 3.46516913 |
| 16 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 3.41905131 |
| 17 | Abnormality of polysaccharide metabolism (HP:0011012) | 3.41905131 |
| 18 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 3.41905131 |
| 19 | Supranuclear gaze palsy (HP:0000605) | 3.39517929 |
| 20 | Atonic seizures (HP:0010819) | 3.37616229 |
| 21 | Thin bony cortex (HP:0002753) | 3.33896615 |
| 22 | Dysostosis multiplex (HP:0000943) | 3.32684647 |
| 23 | Progressive cerebellar ataxia (HP:0002073) | 3.21949438 |
| 24 | Gastrointestinal infarctions (HP:0005244) | 3.16309899 |
| 25 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.15386340 |
| 26 | Mucopolysacchariduria (HP:0008155) | 3.12956653 |
| 27 | Urinary glycosaminoglycan excretion (HP:0003541) | 3.12956653 |
| 28 | Mediastinal lymphadenopathy (HP:0100721) | 3.08984716 |
| 29 | Chronic obstructive pulmonary disease (HP:0006510) | 3.03521713 |
| 30 | Obstructive lung disease (HP:0006536) | 3.03521713 |
| 31 | Ankle clonus (HP:0011448) | 2.94171519 |
| 32 | Generalized tonic-clonic seizures (HP:0002069) | 2.91812611 |
| 33 | Generalized hypopigmentation of hair (HP:0011358) | 2.91097387 |
| 34 | Recurrent fungal infections (HP:0002841) | 2.84026106 |
| 35 | Protruding tongue (HP:0010808) | 2.83830898 |
| 36 | Poor eye contact (HP:0000817) | 2.80812884 |
| 37 | Bundle branch block (HP:0011710) | 2.78985057 |
| 38 | Obstructive sleep apnea (HP:0002870) | 2.78190155 |
| 39 | Abnormal eating behavior (HP:0100738) | 2.74332688 |
| 40 | Absence seizures (HP:0002121) | 2.73175288 |
| 41 | Loss of speech (HP:0002371) | 2.72916550 |
| 42 | Dialeptic seizures (HP:0011146) | 2.70993996 |
| 43 | Broad-based gait (HP:0002136) | 2.65367585 |
| 44 | Systemic lupus erythematosus (HP:0002725) | 2.64972085 |
| 45 | Increased IgE level (HP:0003212) | 2.63999666 |
| 46 | Torticollis (HP:0000473) | 2.59869037 |
| 47 | Recurrent skin infections (HP:0001581) | 2.59279468 |
| 48 | Hemorrhage of the eye (HP:0011885) | 2.58245441 |
| 49 | Annular pancreas (HP:0001734) | 2.57511950 |
| 50 | Impaired social interactions (HP:0000735) | 2.57257207 |
| 51 | Abnormal social behavior (HP:0012433) | 2.57257207 |
| 52 | Polyphagia (HP:0002591) | 2.55258221 |
| 53 | Postural instability (HP:0002172) | 2.54978898 |
| 54 | Hyperventilation (HP:0002883) | 2.54951893 |
| 55 | Meningitis (HP:0001287) | 2.54612769 |
| 56 | Keratoconjunctivitis sicca (HP:0001097) | 2.52415427 |
| 57 | Increased cerebral lipofuscin (HP:0011813) | 2.49979832 |
| 58 | Neuronal loss in central nervous system (HP:0002529) | 2.48972727 |
| 59 | Purpura (HP:0000979) | 2.45689395 |
| 60 | Syncope (HP:0001279) | 2.45486730 |
| 61 | Drooling (HP:0002307) | 2.42863826 |
| 62 | Excessive salivation (HP:0003781) | 2.42863826 |
| 63 | Gingivitis (HP:0000230) | 2.42505229 |
| 64 | Limb dystonia (HP:0002451) | 2.42261902 |
| 65 | Abnormal EKG (HP:0003115) | 2.42204783 |
| 66 | Pustule (HP:0200039) | 2.42164494 |
| 67 | Joint stiffness (HP:0001387) | 2.39580484 |
| 68 | Increased serum ferritin (HP:0003281) | 2.39300028 |
| 69 | Depression (HP:0000716) | 2.38906903 |
| 70 | Neurofibrillary tangles (HP:0002185) | 2.38474388 |
| 71 | Amyloidosis (HP:0011034) | 2.35658583 |
| 72 | Episodic fever (HP:0001954) | 2.35546574 |
| 73 | Keratoconjunctivitis (HP:0001096) | 2.34704318 |
| 74 | Hemoptysis (HP:0002105) | 2.33370029 |
| 75 | J-shaped sella turcica (HP:0002680) | 2.32016188 |
| 76 | Prolonged QT interval (HP:0001657) | 2.31731480 |
| 77 | Decreased circulating renin level (HP:0003351) | 2.29863399 |
| 78 | Peritonitis (HP:0002586) | 2.29158898 |
| 79 | Anxiety (HP:0000739) | 2.28337819 |
| 80 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.28081958 |
| 81 | Stereotypic behavior (HP:0000733) | 2.27841219 |
| 82 | Failure to thrive in infancy (HP:0001531) | 2.25994549 |
| 83 | Vasculitis (HP:0002633) | 2.25325651 |
| 84 | Focal dystonia (HP:0004373) | 2.25213677 |
| 85 | Ventricular fibrillation (HP:0001663) | 2.25099471 |
| 86 | Prolonged bleeding time (HP:0003010) | 2.24274151 |
| 87 | Petechiae (HP:0000967) | 2.21807533 |
| 88 | Genetic anticipation (HP:0003743) | 2.20410356 |
| 89 | Progressive inability to walk (HP:0002505) | 2.20286984 |
| 90 | Cervical subluxation (HP:0003308) | 2.19187745 |
| 91 | Polygenic inheritance (HP:0010982) | 2.17625990 |
| 92 | Epileptiform EEG discharges (HP:0011182) | 2.16600699 |
| 93 | Pulmonary infiltrates (HP:0002113) | 2.16475564 |
| 94 | Absent speech (HP:0001344) | 2.16371409 |
| 95 | Encephalitis (HP:0002383) | 2.15265894 |
| 96 | Cellulitis (HP:0100658) | 2.14572477 |
| 97 | Gait imbalance (HP:0002141) | 2.14232719 |
| 98 | Abnormality of the nasal mucosa (HP:0000433) | 2.14118117 |
| 99 | Hypochromic anemia (HP:0001931) | 2.13487526 |
| 100 | Abnormal hair whorl (HP:0010721) | 2.12350494 |
| 101 | Craniofacial dystonia (HP:0012179) | 2.12174084 |
| 102 | Testicular atrophy (HP:0000029) | 2.11976895 |
| 103 | Fair hair (HP:0002286) | 2.10006798 |
| 104 | Anosmia (HP:0000458) | 2.08126046 |
| 105 | Spontaneous hematomas (HP:0007420) | 2.07251119 |
| 106 | Cerebral aneurysm (HP:0004944) | 2.06159164 |
| 107 | Emphysema (HP:0002097) | 2.06118801 |
| 108 | Gaze-evoked nystagmus (HP:0000640) | 2.05965865 |
| 109 | Left ventricular hypertrophy (HP:0001712) | 2.05770988 |
| 110 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.05621102 |
| 111 | Recurrent cutaneous fungal infections (HP:0011370) | 2.05621102 |
| 112 | EEG with generalized epileptiform discharges (HP:0011198) | 2.05542527 |
| 113 | Primary atrial arrhythmia (HP:0001692) | 2.05444797 |
| 114 | Nuclear cataract (HP:0100018) | 2.05278950 |
| 115 | Hemiparesis (HP:0001269) | 2.05076054 |
| 116 | Atrial fibrillation (HP:0005110) | 2.04960077 |
| 117 | Exercise-induced myalgia (HP:0003738) | 2.04678286 |
| 118 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.04432616 |
| 119 | Abnormality of salivation (HP:0100755) | 2.04380651 |
| 120 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.03996726 |
| 121 | Colitis (HP:0002583) | 2.03280699 |
| 122 | Easy fatigability (HP:0003388) | 2.03090548 |
| 123 | Thyroid-stimulating hormone excess (HP:0002925) | 2.02760010 |
| 124 | Stridor (HP:0010307) | 2.02681776 |
| 125 | Inability to walk (HP:0002540) | 2.02658934 |
| 126 | Sudden death (HP:0001699) | 2.00315257 |
| 127 | Papilledema (HP:0001085) | 1.99423756 |
| 128 | Epistaxis (HP:0000421) | 1.98790126 |
| 129 | Truncal ataxia (HP:0002078) | 1.98748566 |
| 130 | Status epilepticus (HP:0002133) | 1.98715122 |
| 131 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.97901961 |
| 132 | Retinal atrophy (HP:0001105) | 1.96269421 |
| 133 | Acne (HP:0001061) | 1.95877753 |
| 134 | Abnormality of the endocardium (HP:0004306) | 1.95709429 |
| 135 | Nasal polyposis (HP:0100582) | 1.95464621 |
| 136 | Iris hypopigmentation (HP:0007730) | 1.95354285 |
| 137 | Dysmetria (HP:0001310) | 1.94803214 |
| 138 | Axonal loss (HP:0003447) | 1.94506110 |
| 139 | Medial flaring of the eyebrow (HP:0010747) | 1.94226704 |
| 140 | Gastrointestinal inflammation (HP:0004386) | 1.93952516 |
| 141 | Hypsarrhythmia (HP:0002521) | 1.93480511 |
| 142 | Urticaria (HP:0001025) | 1.93216172 |
| 143 | Malnutrition (HP:0004395) | 1.93175986 |
| 144 | Mutism (HP:0002300) | 1.92655213 |
| 145 | Impaired vibration sensation in the lower limbs (HP:0002166) | 1.92459987 |
| 146 | Abnormality of iron homeostasis (HP:0011031) | 1.92340507 |
| 147 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.91715495 |
| 148 | Anorexia (HP:0002039) | 1.90697141 |
| 149 | Ulnar bowing (HP:0003031) | 1.90505710 |
| 150 | Generalized hypopigmentation (HP:0007513) | 1.90315465 |
| 151 | Supraventricular tachycardia (HP:0004755) | 1.89548009 |
| 152 | Hepatosplenomegaly (HP:0001433) | 1.89039573 |
| 153 | Sleep apnea (HP:0010535) | 1.88270557 |
| 154 | Inflammation of the large intestine (HP:0002037) | 1.85889761 |
| 155 | Tented upper lip vermilion (HP:0010804) | 1.85411756 |
| 156 | Fetal akinesia sequence (HP:0001989) | 1.85312751 |
| 157 | Dysdiadochokinesis (HP:0002075) | 1.85309039 |
| 158 | Broad face (HP:0000283) | 1.85279447 |
| 159 | Hypothermia (HP:0002045) | 1.84296161 |
| 160 | Vacuolated lymphocytes (HP:0001922) | 1.82881826 |
| 161 | Turricephaly (HP:0000262) | 1.82483673 |
| 162 | Rapidly progressive (HP:0003678) | 1.81402951 |
| 163 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.80665043 |
| 164 | Blue irides (HP:0000635) | 1.79920343 |
| 165 | Abnormality of binocular vision (HP:0011514) | 1.79434267 |
| 166 | Diplopia (HP:0000651) | 1.79434267 |
| 167 | Nephrogenic diabetes insipidus (HP:0009806) | 1.79385911 |
| 168 | Chest pain (HP:0100749) | 1.78913640 |
| 169 | Retinal dysplasia (HP:0007973) | 1.78472605 |
| 170 | Pulmonary embolism (HP:0002204) | 1.78234095 |
| 171 | Joint hemorrhage (HP:0005261) | 1.78125411 |
| 172 | Hyperacusis (HP:0010780) | 1.77950949 |
| 173 | Supraventricular arrhythmia (HP:0005115) | 1.77722702 |
| 174 | Intellectual disability, severe (HP:0010864) | 1.77663220 |
| 175 | Agitation (HP:0000713) | 1.77142803 |
| 176 | Calf muscle hypertrophy (HP:0008981) | 1.77024097 |
| 177 | Insomnia (HP:0100785) | 1.76842018 |
| 178 | Interstitial pulmonary disease (HP:0006530) | 1.76621252 |
| 179 | Action tremor (HP:0002345) | 1.75755982 |
| 180 | Bradycardia (HP:0001662) | 1.75665368 |
| 181 | Elfin facies (HP:0004428) | 1.75245375 |
| 182 | Lower limb amyotrophy (HP:0007210) | 1.74128485 |
| 183 | Congenital primary aphakia (HP:0007707) | 1.74082601 |
| 184 | Urinary urgency (HP:0000012) | 1.73946439 |
| 185 | Cortical visual impairment (HP:0100704) | 1.73094803 |
| 186 | Exotropia (HP:0000577) | 1.72494517 |
| 187 | Abnormality of glycolipid metabolism (HP:0010969) | 1.72004813 |
| 188 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.72004813 |
| 189 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.72004813 |
| 190 | Hypoventilation (HP:0002791) | 1.71598875 |
| 191 | Psychosis (HP:0000709) | 1.70632526 |
| 192 | Amblyopia (HP:0000646) | 1.69241714 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NTRK3 | 3.66849337 |
| 2 | ERN1 | 3.15354198 |
| 3 | MAP4K1 | 3.14247276 |
| 4 | TRIB3 | 3.10957072 |
| 5 | EPHA4 | 3.10952483 |
| 6 | TNIK | 2.90116950 |
| 7 | MARK1 | 2.80256451 |
| 8 | DAPK2 | 2.76284798 |
| 9 | SIK3 | 2.50147758 |
| 10 | MAP2K7 | 2.46018350 |
| 11 | SIK1 | 2.35694369 |
| 12 | RIPK4 | 2.33355993 |
| 13 | SIK2 | 2.33309310 |
| 14 | CASK | 2.28000092 |
| 15 | MAP3K4 | 2.22457640 |
| 16 | MINK1 | 2.16884771 |
| 17 | TYK2 | 2.06094649 |
| 18 | MAP3K11 | 1.89945705 |
| 19 | IRAK3 | 1.85819467 |
| 20 | ZAP70 | 1.85138957 |
| 21 | MAP2K4 | 1.83152261 |
| 22 | GRK6 | 1.76177801 |
| 23 | RIPK1 | 1.75069213 |
| 24 | CAMKK1 | 1.74428522 |
| 25 | MAP3K9 | 1.69886531 |
| 26 | MAPK13 | 1.68301091 |
| 27 | TAOK1 | 1.67852449 |
| 28 | EPHB1 | 1.63596441 |
| 29 | PRPF4B | 1.62707509 |
| 30 | CSK | 1.60681571 |
| 31 | PAK6 | 1.58044557 |
| 32 | BMPR2 | 1.56925420 |
| 33 | NTRK2 | 1.55863991 |
| 34 | MAP3K3 | 1.46914476 |
| 35 | SGK2 | 1.46262247 |
| 36 | FES | 1.44778703 |
| 37 | MAP3K13 | 1.42935302 |
| 38 | SGK223 | 1.40746552 |
| 39 | SGK494 | 1.40746552 |
| 40 | CDC42BPA | 1.39352240 |
| 41 | UHMK1 | 1.38130555 |
| 42 | TAOK2 | 1.31063508 |
| 43 | PHKG1 | 1.29055131 |
| 44 | PHKG2 | 1.29055131 |
| 45 | SGK3 | 1.25123814 |
| 46 | KSR1 | 1.24002672 |
| 47 | STK38 | 1.17948582 |
| 48 | PINK1 | 1.17752976 |
| 49 | JAK3 | 1.14874042 |
| 50 | MAP3K12 | 1.14850868 |
| 51 | SMG1 | 1.14779461 |
| 52 | PTK6 | 1.14681102 |
| 53 | DAPK1 | 1.14603440 |
| 54 | CAMK1 | 1.14196121 |
| 55 | MAP3K14 | 1.11194877 |
| 56 | MAP3K1 | 1.10026092 |
| 57 | CAMK1G | 1.09690181 |
| 58 | IRAK2 | 1.08248013 |
| 59 | INSRR | 1.07161990 |
| 60 | CDK5 | 1.06507691 |
| 61 | PRKD3 | 1.04190980 |
| 62 | CAMK4 | 1.04054932 |
| 63 | PDPK1 | 1.03056862 |
| 64 | FGR | 1.01641698 |
| 65 | MAP2K6 | 1.01502077 |
| 66 | IRAK4 | 1.01169093 |
| 67 | BTK | 1.01066730 |
| 68 | MAP3K7 | 1.01031682 |
| 69 | DMPK | 0.98740576 |
| 70 | MAPK15 | 0.97528589 |
| 71 | ICK | 0.97348674 |
| 72 | MARK2 | 0.96416758 |
| 73 | PRKCH | 0.96149666 |
| 74 | FGFR4 | 0.95903315 |
| 75 | IKBKB | 0.93825374 |
| 76 | RPS6KA2 | 0.90503875 |
| 77 | CAMKK2 | 0.84132933 |
| 78 | JAK2 | 0.83937604 |
| 79 | GRK7 | 0.83718557 |
| 80 | PKN2 | 0.83094250 |
| 81 | ERBB3 | 0.81687958 |
| 82 | JAK1 | 0.81408957 |
| 83 | BMX | 0.81160698 |
| 84 | NME2 | 0.79376747 |
| 85 | TESK1 | 0.79142711 |
| 86 | PDK1 | 0.77673396 |
| 87 | DYRK1B | 0.77331635 |
| 88 | MATK | 0.77173821 |
| 89 | CAMK2A | 0.77020199 |
| 90 | PIK3CG | 0.74950101 |
| 91 | LMTK2 | 0.72688004 |
| 92 | BLK | 0.72257786 |
| 93 | CLK1 | 0.71784672 |
| 94 | CDK3 | 0.71528984 |
| 95 | MAP3K6 | 0.71490330 |
| 96 | RPS6KL1 | 0.71359175 |
| 97 | RPS6KC1 | 0.71359175 |
| 98 | LYN | 0.70492287 |
| 99 | WNK3 | 0.70332172 |
| 100 | SGK1 | 0.70057389 |
| 101 | CAMK2B | 0.68779073 |
| 102 | NTRK1 | 0.68462490 |
| 103 | HIPK2 | 0.66978005 |
| 104 | CSF1R | 0.66840698 |
| 105 | PKN1 | 0.66781922 |
| 106 | IRAK1 | 0.66505789 |
| 107 | PRKCG | 0.65856273 |
| 108 | DDR2 | 0.65362297 |
| 109 | CAMK2D | 0.64431979 |
| 110 | PRKCE | 0.64061759 |
| 111 | PRKG2 | 0.62519185 |
| 112 | PRKCZ | 0.62222096 |
| 113 | MARK3 | 0.58669109 |
| 114 | RPS6KA6 | 0.58450462 |
| 115 | ADRBK2 | 0.57649591 |
| 116 | CDK18 | 0.55730943 |
| 117 | TYRO3 | 0.55692392 |
| 118 | LCK | 0.54690287 |
| 119 | TESK2 | 0.53022563 |
| 120 | SYK | 0.52643390 |
| 121 | DYRK1A | 0.52094254 |
| 122 | MAPK12 | 0.50298159 |
| 123 | FYN | 0.49315030 |
| 124 | BCR | 0.48886394 |
| 125 | PAK3 | 0.48663879 |
| 126 | STK11 | 0.47542068 |
| 127 | CDK15 | 0.45755065 |
| 128 | BRD4 | 0.45488452 |
| 129 | HCK | 0.45158357 |
| 130 | GRK5 | 0.44908065 |
| 131 | MAPK7 | 0.44403771 |
| 132 | CDK19 | 0.44323011 |
| 133 | CCNB1 | 0.42876593 |
| 134 | PRKG1 | 0.42382441 |
| 135 | PTK2B | 0.41967003 |
| 136 | CAMK1D | 0.41571850 |
| 137 | ARAF | 0.41415829 |
| 138 | TGFBR2 | 0.41259919 |
| 139 | CDK11A | 0.40935624 |
| 140 | NEK6 | 0.40884702 |
| 141 | PIM2 | 0.40159696 |
| 142 | PRKD1 | 0.40042272 |
| 143 | ITK | 0.38949680 |
| 144 | RET | 0.38473027 |
| 145 | KSR2 | 0.37958873 |
| 146 | MAP2K3 | 0.37780484 |
| 147 | TBK1 | 0.36632455 |
| 148 | ERBB2 | 0.36470092 |
| 149 | RPS6KA3 | 0.36321585 |
| 150 | MAP2K2 | 0.36211027 |
| 151 | CHUK | 0.35795247 |
| 152 | TXK | 0.34919364 |
| 153 | PRKD2 | 0.34880578 |
| 154 | BRAF | 0.34795244 |
| 155 | TNK2 | 0.34392586 |
| 156 | IKBKE | 0.34089253 |
| 157 | KIT | 0.32099198 |
| 158 | MAPK4 | 0.32000888 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 3.40441929 |
| 2 | Other glycan degradation_Homo sapiens_hsa00511 | 2.81681576 |
| 3 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.76166307 |
| 4 | Olfactory transduction_Homo sapiens_hsa04740 | 2.74763497 |
| 5 | Circadian entrainment_Homo sapiens_hsa04713 | 2.36963610 |
| 6 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.34474084 |
| 7 | Morphine addiction_Homo sapiens_hsa05032 | 2.34052086 |
| 8 | GABAergic synapse_Homo sapiens_hsa04727 | 2.22267943 |
| 9 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.16163959 |
| 10 | Insulin secretion_Homo sapiens_hsa04911 | 2.02467494 |
| 11 | Tuberculosis_Homo sapiens_hsa05152 | 1.88930060 |
| 12 | Taste transduction_Homo sapiens_hsa04742 | 1.87294957 |
| 13 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.85319543 |
| 14 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.79530087 |
| 15 | Malaria_Homo sapiens_hsa05144 | 1.74970172 |
| 16 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.72988875 |
| 17 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.72291863 |
| 18 | Cocaine addiction_Homo sapiens_hsa05030 | 1.72020274 |
| 19 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.71136366 |
| 20 | Salivary secretion_Homo sapiens_hsa04970 | 1.67099375 |
| 21 | Long-term potentiation_Homo sapiens_hsa04720 | 1.62759086 |
| 22 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.61576666 |
| 23 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.58556982 |
| 24 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.56816019 |
| 25 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.54954750 |
| 26 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.52233541 |
| 27 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.52143682 |
| 28 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.47976988 |
| 29 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.47019263 |
| 30 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.44493858 |
| 31 | Allograft rejection_Homo sapiens_hsa05330 | 1.43536145 |
| 32 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.43166446 |
| 33 | Renin secretion_Homo sapiens_hsa04924 | 1.42018164 |
| 34 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.41185754 |
| 35 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.37773723 |
| 36 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.36527938 |
| 37 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.35980466 |
| 38 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.32931768 |
| 39 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.30456245 |
| 40 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.27548644 |
| 41 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.26890946 |
| 42 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.24734670 |
| 43 | Influenza A_Homo sapiens_hsa05164 | 1.24517362 |
| 44 | Hepatitis C_Homo sapiens_hsa05160 | 1.23093588 |
| 45 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.19911525 |
| 46 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.19227945 |
| 47 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 1.19013970 |
| 48 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.17166959 |
| 49 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.14854033 |
| 50 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.10691852 |
| 51 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.10272241 |
| 52 | Salmonella infection_Homo sapiens_hsa05132 | 1.08446722 |
| 53 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.06372157 |
| 54 | Phagosome_Homo sapiens_hsa04145 | 1.05771228 |
| 55 | Long-term depression_Homo sapiens_hsa04730 | 1.05739321 |
| 56 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.05611906 |
| 57 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.04359350 |
| 58 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.02505655 |
| 59 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.02375211 |
| 60 | Legionellosis_Homo sapiens_hsa05134 | 1.01929987 |
| 61 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.00726935 |
| 62 | Measles_Homo sapiens_hsa05162 | 1.00447443 |
| 63 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.99592392 |
| 64 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.99199680 |
| 65 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.96550610 |
| 66 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.95499591 |
| 67 | Axon guidance_Homo sapiens_hsa04360 | 0.94903290 |
| 68 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.94124875 |
| 69 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.93404802 |
| 70 | Endocytosis_Homo sapiens_hsa04144 | 0.90723800 |
| 71 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.89041302 |
| 72 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.88764595 |
| 73 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.88185053 |
| 74 | Hepatitis B_Homo sapiens_hsa05161 | 0.87936049 |
| 75 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.87435991 |
| 76 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.86212634 |
| 77 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.85548153 |
| 78 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.84983238 |
| 79 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.82947346 |
| 80 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.82001438 |
| 81 | Bladder cancer_Homo sapiens_hsa05219 | 0.81676109 |
| 82 | Amoebiasis_Homo sapiens_hsa05146 | 0.81028167 |
| 83 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.80569100 |
| 84 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.80505397 |
| 85 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.78674187 |
| 86 | Sulfur relay system_Homo sapiens_hsa04122 | 0.76643444 |
| 87 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.76185350 |
| 88 | ABC transporters_Homo sapiens_hsa02010 | 0.75246981 |
| 89 | Apoptosis_Homo sapiens_hsa04210 | 0.75128407 |
| 90 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.73665774 |
| 91 | Gap junction_Homo sapiens_hsa04540 | 0.73579667 |
| 92 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.73069948 |
| 93 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.73025943 |
| 94 | Asthma_Homo sapiens_hsa05310 | 0.72762872 |
| 95 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.71637935 |
| 96 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.71016917 |
| 97 | Platelet activation_Homo sapiens_hsa04611 | 0.69462806 |
| 98 | Viral myocarditis_Homo sapiens_hsa05416 | 0.68528968 |
| 99 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.67637306 |
| 100 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.67245038 |
| 101 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.66494961 |
| 102 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.66207402 |
| 103 | Circadian rhythm_Homo sapiens_hsa04710 | 0.65307019 |
| 104 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.65302858 |
| 105 | Shigellosis_Homo sapiens_hsa05131 | 0.63586277 |
| 106 | Glioma_Homo sapiens_hsa05214 | 0.63535462 |
| 107 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.63053164 |
| 108 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.61954021 |
| 109 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.61698936 |
| 110 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.60737909 |
| 111 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.60371173 |
| 112 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.60143337 |
| 113 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.60054903 |
| 114 | Insulin resistance_Homo sapiens_hsa04931 | 0.59842601 |
| 115 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.57879256 |
| 116 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.57471068 |
| 117 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.56456237 |
| 118 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.56408121 |
| 119 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.56257884 |
| 120 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.55158912 |
| 121 | Melanogenesis_Homo sapiens_hsa04916 | 0.54881682 |
| 122 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.53284488 |
| 123 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.53090999 |
| 124 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.52848163 |
| 125 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.51730879 |
| 126 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.51196502 |
| 127 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.49835171 |
| 128 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.49255467 |
| 129 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.48707398 |
| 130 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.48219200 |
| 131 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.47045219 |
| 132 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.46568559 |
| 133 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.45745916 |
| 134 | Lysine degradation_Homo sapiens_hsa00310 | 0.44387159 |
| 135 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.43925503 |
| 136 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.42845829 |
| 137 | Bile secretion_Homo sapiens_hsa04976 | 0.42729306 |
| 138 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.42427098 |
| 139 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.42268289 |
| 140 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.41559426 |
| 141 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.40598447 |
| 142 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.40411929 |
| 143 | Prion diseases_Homo sapiens_hsa05020 | 0.39595903 |
| 144 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.39460579 |
| 145 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.39431056 |
| 146 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.39146300 |
| 147 | Pertussis_Homo sapiens_hsa05133 | 0.39053755 |
| 148 | Leishmaniasis_Homo sapiens_hsa05140 | 0.38548987 |
| 149 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.37278522 |
| 150 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.37013405 |
| 151 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.36985224 |
| 152 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.36908727 |
| 153 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.35917956 |
| 154 | Alzheimers disease_Homo sapiens_hsa05010 | 0.35327568 |
| 155 | Lysosome_Homo sapiens_hsa04142 | 0.33908342 |

